Gene splicing found to reduce effectiveness of CD20-targeting monoclonal antibodies for blood cancers and disorders
Immunotherapies that target the CD20 antigen have revolutionized how patients with a variety of blood cancers and hematologic disorders have been treated. However, many patients develop resistance to these treatments due ...
Nov 16, 2023
0
0